MAPT and Alzheimer disease: A systematic review and meta-analysis of 231 articles comprising 15699 patients with AD and 13018 controls showed that 42 amino-acid-long amyloid-β peptide (Aβ1-42), total tau (T-tau), and phosphorylated tau (P-tau) are surrogate biomarkers of AD [66].